Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
clinical trial data
Pharma
Incyte posts mixed Opzelura results in prurigo nodularis
As Incyte strives to push Opzelura into new dermatology indications, the company’s latest data drop in prurigo nodularis is a bit of a mixed bag.
Fraiser Kansteiner
Mar 10, 2025 11:23am
Roche's Itovebi pads its case with overall survival win
Jan 28, 2025 4:00pm
In weight loss trial, Lilly's Zepbound tops Novo's Wegovy
Dec 4, 2024 6:45am
Novo's oral semaglutide shows heart benefits
Oct 21, 2024 10:09am
Merck's Welireg again comes up short in OS but excels in PFS
Sep 13, 2024 8:00am
FDA noted 'large number' of missing AEs in Amgen's Imdelltra app
Aug 14, 2024 6:45am
